MAXCYTE INC

MAXCYTE INC

Share · US57777K1060 · MXCT · A2AGVE (XLON)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MAXCYTE INC
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
2
0
0
No Price
29.04.2026 05:27
Current Prices from MAXCYTE INC
ExchangeTickerCurrencyLast TradePriceDaily Change
XDQU: Quotrix
Quotrix
MCIRSD60.DUSD
EUR
29.04.2026 05:27
0,75 EUR
-0,01 EUR
-1,32 %
XNAS: NASDAQ
NASDAQ
MXCT
USD
28.04.2026 22:41
0,86 USD
-0,01 USD
-1,60 %
IEXG: IEX
IEX
MXCT
USD
28.04.2026 19:59
0,88 USD
0,005 USD
+0,58 %
XDUS: Düsseldorf
Düsseldorf
MCIRSD60.DUSB
EUR
28.04.2026 17:31
0,73 EUR
-0,04 EUR
-4,61 %
Share Float & Liquidity
Free Float 92,33 %
Shares Float 98,67 M
Shares Outstanding 106,86 M
Company Profile for MAXCYTE INC Share
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

Company Data

Name MAXCYTE INC
Company MaxCyte, Inc.
Symbol MXCT
Website https://maxcyte.com
Primary Exchange XLON London
WKN A2AGVE
ISIN US57777K1060
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Maher Masoud
Market Capitalization 157 Mio
Country United States of America
Currency EUR
Employees 0,1 T
Address 9713 Key West Avenue, 20850 Rockville
IPO Date 2016-03-29

Ticker Symbols

Name Symbol
Düsseldorf MCIRSD60.DUSB
Frankfurt MYE0.F
London MXCT.L
NASDAQ MXCT
Quotrix MCIRSD60.DUSD
More Shares
Investors who hold MAXCYTE INC also have the following shares in their portfolio:
ALPHA BANK ADR1/4/EO 3,90
ALPHA BANK ADR1/4/EO 3,90 Depository Receipt
META PLATF. 22/62 REGS
META PLATF. 22/62 REGS Bond